Ružić, Dušan

Type

Date issued

92 2000 - 2027

Mp-cat.

Date issued - custom

Year from:

Year to:

Results 41-60 of 92 Results/Page

Issue Date	Title	Author(s)	Type	Мp-cat.
2021	Discovery of potential multi-target-directed 5-HT2A receptor ligands	Radan, Milica M. ; Dušan Ružić ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2021	Fragment-Based Drug Design of Selective HDAC6 Inhibitors	Ružić, PhD, Dušan	Book parts	Mp. category will be shown later
2021	Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors	Ruzic, Dušan ; Đoković, Nemanja B. ; Bon C.; Petkovic, M. ; Ellinger B.; Gul, S.; Santibanez F. J.; Lahtela-Kakkonen, M.; Halby L.; Ganesan, A.; Srdic-Rajic T. ; Arimondo P.; Nikolić, Katarina M. ;	Conference Paper	Mp. category will be shown later
2021	Synthesis and biological activity of a cytostatic inhibitor of MLLr leukemia targeting the DOT1L protein	Bon, Corentin; Si, Yang; Pernak, Melanie; Barbachowska, Magdalena; Levi-Acobas, Eva; Cadet Daniel, Veronique; Jallet, Corinne; Ružić, Dušan ; Đoković, Nemanja ; Đikić, Teodora ; Nikolić, Katarina ; Halby, Ludovic; Arimondo, Paola B.;	Article	21M21
2021	Design of dual cyclooxygenase-2 and 5-lipoxygenase inhibitors with iron-chelating properties – molecular docking	Bošković, Jelena ; Ružić, Dušan ; Čudina, Olivera ; Nikolić, Katarina ; Dobričić, Vladimir	Conference Paper	Mp. category will be shown later
2021	An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease	Đoković, Nemanja ; Ružić, Dušan ; Đikić, Teodora ; Cvijić, Sandra ; Ignjatović, Jelisaveta ; Ibrić, Svetlana ; Baralić, Katarina ; Buha-Đorđević, Aleksandra ; Ćurčić, Marijana ; Đukić-Ćosić, Danijela ; Nikolić, Katarina ;	Article	21M21
2021	Novel 1-benzhydryl piperazine derivative inhibits the migration and invasiveness of breast cancer cells: Synthesis, molecular modelling and biological characterization	Ružić, Dušan ; Petković, Miloš ; Gul, Sheraz; Santibanez, Juan ; Srdić-Rajić, Tatjana ; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2021	Synthesis, molecular modelling and biological characterization of novel antimigratory and antiinvasive 1-benzhydryl piperazine derivatives	Dusan Ruzic ; Milos Petkovic ; E. Bernhard; Sheraz Gul; J.F. Santibanez; Tatjana Srdic Rajic ; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2020	Combined ligand-based and structure-based approaches in rational drug design of novel 5-HT2A receptor antagonists	Radan, Milica M. ; Ružić, Dušan B. ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2020	In silico rational druga design and modelling studies of novel 5-HT2A receptor antagonsts	Radan, Milica ; Ružić, Dušan ; Antonijević, Mirjana; Đikić, Teodora ; Nikolić, Katarina	Conference Paper	Mp. category will be shown later
2020	In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs	Gagić, Žarko ; Ružić, Dušan ; Đoković, Nemanja ; Đikić, Teodora ; Nikolić, Katarina	Article	21M21
2020	Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies	Radan, Milica M. ; Ružić, Dušan B. ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2020	In silico rational drug design and modelling studies of novel 5-HT2A receptor antagonists	Radan, Milica M. ; Ružić, Dušan B. ; Mirjana Antonijevic; Teodora Djikic; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2020	COST Action 17104 (STRATAGEM), WG2 Meeting and International Online Symposium on: Multitargeting epi-epi drugs for multidrug resistance	Adam Lee; A. Ganesan; I. Bulut; Ceyda Açılan Ayhan; Ružić, Dušan B. ; Nikolić, Katarina M. ; Sheraz Gul	Conference Paper	Mp. category will be shown later
2020	In silico Identification of Novel 5-HT2A Antagonists Supported with Ligand- and Target- Based Drug Design Methodologies	Radan, Milica ; Ružić, Dušan ; Antonijevic, Mirjana; Djikic, Teodora; Nikolić, Katarina	Article	21M21
2020	Multitargeting epi-epi drugs for multidrug reistance	Lee, Adam; Ganesan, A.; Bulut, İpek; Açılan Ayhan, Ceyda; Ružić, Dušan ; Nikolić, Katarina ; Gul, Sheraz	Conference Paper	Mp. category will be shown later
2019	Combined 3D-QSAR modeling, molecular dynamics and molecular docking studies in rational drug design of novel 5-HT2A antagonists	Radan, Milica M. ; Mirjana Antonijevic; Đikić, Teodora M. ; Ružić, Dušan B. ; Nikolić, Katarina M.	Conference Paper	Mp. category will be shown later
2019	Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling	Bouchet, Samuel; Linot, Camille; Ružić, Dušan ; Agbaba, Danica ; Fouchaq, Benoit; Roche, Joelle; Nikolić, Katarina ; Blanquart, Christophe; Bertrand, Philippe	Article	21M21
2019	Modulating Protein-Protein Interactions with Visible-Light-Responsive Peptide Backbone Photoswitches	Albert, Lea; Penalver, Alberto; Đoković, Nemanja ; Werel, Laura; Hoffarth, Malte; Ružić, Dušan ; Xu, Jing; Essen, Lars-Oliver; Nikolić, Katarina ; Dou, Yali; Vazquez, Olalla;	Article	22M22
2019	Structure-Based Design of Selective Histone Deacetylase 6 Zinc Binding Groups	Alves, Avelar Leandro A.; Ružić, Dušan ; Đoković, Nemanja ; Kurz, Thomas; Nikolić, Katarina	Article	21M21